Quintiles

Quintiles

Helps pharmaceutical, biotechnology and medical device companies develop and market innovative therapies.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
investor

€0.0

round
investor investor

€0.0

round
N/A

€0.0

round

$9.0b

Merger
Total Funding000k
Citi
Citi(exited)
TPG
TPG(exited)
3i Group
3i Group(exited)

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
GBP20152016
Revenues00000000
% growth-147 %
EBITDA00000000
% EBITDA margin3 %12 %
Profit00000000
% profit margin4 %12 %
EV00000000
EV / revenue00.0x00.0x
EV / EBITDA00.0x00.0x
R&D budget00000000
R&D % of revenue792 %-

Source: Company filings or news article

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Quintiles

Edit
Advion
ACQUISITION by Quintiles Oct 2011
VCG & Associates
ACQUISITION by Quintiles Oct 2011
Novella
ACQUISITION by Quintiles Sep 2013
Eidetics
ACQUISITION by Quintiles May 2008
NitroMed
ACQUISITION by Deerfield Capital Management Jan 2009